Liver Transplantation Center, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, China.
Chin Med J (Engl). 2009 Nov 5;122(21):2598-602.
Only a few reviews of small case series and individual case reports including a relatively small number of adult patients undergoing liver transplantation for hepatopulmonary syndrome (HPS) are available, and there has been no prospective evaluation of the long-term outcome of HPS patients after orthotopic liver transplantation (OLT). The aim of this study was to determine the frequency of HPS in OLT patients with chronic end-stage liver-disease, and the short-term and long-term postoperative outcome of HPS patients after OLT.
This prospective study included 31 HPS and 30 control, non-HPS patients. The preoperative conditions were similar between the two groups. Twenty-six of 31 HPS patients and all of the non-HPS patients underwent OLT. Standardized methods, such as arterial blood gas at room air and 99m-technetium macroaggregated albumin ((99m)Tc MAA) lung and brain perfusion scanning were performed for the diagnosis of HPS. Patients were followed after OLT.
The incidence of HPS in OLT patients was 9.3% (26/279). Hypoxemia in HPS was obviously improved with a normalized shunt of (99m)Tc MAA in the lungs after OLT. The immediate postoperative survival rate (within 28 days after OLT) of HPS was 76.9% (20/26). The one year survival was 61.5% (16/26) and four-year survival was 57.7% (15/26); much higher than HPS patients without OLT (0). But high postoperative morbidity and mortality were observed in HPS patients whose death occurred within 3 months of OLT due to complications summarized in this study.
Liver transplantation was an effective treatment for HPS. But the postoperative mortality rate following OLT in HPS patients was still much higher than that of patients without HPS.
仅有少数小病例系列和个别病例报告的综述,包括相对较少的成人患者接受肝移植治疗肝肺综合征(HPS),并且没有对 HPS 患者肝移植(OLT)后的长期预后进行前瞻性评估。本研究旨在确定慢性终末期肝病患者 OLT 中 HPS 的频率,以及 OLT 后 HPS 患者的短期和长期术后结果。
这项前瞻性研究包括 31 例 HPS 和 30 例非 HPS 对照患者。两组的术前情况相似。31 例 HPS 中有 26 例和所有非 HPS 患者均接受了 OLT。采用动脉血气分析在室气和 99m 锝聚合白蛋白(99mTc MAA)肺和脑灌注扫描等标准方法诊断 HPS。OLT 后对患者进行随访。
OLT 患者中 HPS 的发生率为 9.3%(26/279)。HPS 中的低氧血症在 OLT 后明显改善,肺内 99mTc MAA 分流正常。HPS 的即时术后生存率(OLT 后 28 天内)为 76.9%(20/26)。一年生存率为 61.5%(16/26),四年生存率为 57.7%(15/26);远高于未接受 OLT 的 HPS 患者(0)。但在本研究中总结的并发症导致 HPS 患者在 OLT 后 3 个月内死亡,其术后发病率和死亡率较高。
肝移植是 HPS 的有效治疗方法。但 HPS 患者 OLT 后的死亡率仍远高于无 HPS 患者。